Novogen CEO to be interviewed on WABC New York, page-39

No hesitation re trials in my view, don't over think it.

Graham has clearly outlined in his blog his strategy - raise enough capital to guarantee these trials will progress. He's clearly done that.

The Cantrixil trial will commence around Dec 2015, Trilexium and Anisina in H1 2016.

Nothing to hesitate about - this is fantastic progress imo and as Graham said, they have a team working on the trials day & night now to make them happen.

Thanks for making us aware of the interview.